相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 服务名称:
Lung Cancer qBiomarker Copy Number PCR Arrays 肺癌qBiomarker拷贝数PCR芯片
- 提供商:
SAbiosciences
技术服务网址:http://www.yingbio.com/
服务热线:400-696-6643、 18019265738
邮箱:daihp@yingbio.com 、 huizhang1228@foxmail.com
Lung Cancer qBiomarker Copy Number PCR Arrays
肺癌qBiomarker拷贝数PCR芯片
| Product | Species | Technology | Cat. No. |
| Lung Cancer qBiomarker Copy Number PCR Arrays | Human | Copy Number | VAHS-0056Z |
96-well Plate, 384-well (4 × 96) Plate, and 100-well Disc formats are available.
肺癌qBiomarker拷贝数PCR芯片用于研究人类肺肿瘤相关且发生频繁突变的23个基因的拷贝数。最近的研究发现基因拷贝数变化是疾病发生和进程的主要调节机制。这个芯片编码转录因子、受体和调节细胞周期和DNA损伤修复等过程的生长因子这些基因来自主要文献评论和公共数据库中与人类肺癌生物学相关的最频繁扩增或缺失的基因。这个芯片可做为帮助分类肺癌样本基因型并验证表型生物标记的有效工具。这个芯片可以使每个基因在每个样本中有四个重复,同时包含一个稳定的多拷贝参考实验,通过适当的DNA插入标准化精确检测拷贝数。简单的产品模式和操作程序让任何一个具备实时定量PCR仪的实验室都可进行常规可靠的拷贝数检测。
qBiomarker拷贝数PCR芯片用于分子生物学应用。本产品不用于疾病的诊断、预防和治疗。
提供96孔板,384 -(4×96)板,和100 孔。
Non-Small Cell Lung Cancers (NSCLC): CCND1, CDKN2A, CSMD1, EGFR, KRAS, MET, MYC, PIK3CA.
Lapatinib Sensitivity: CDKN2A.
AKT & PI-3-Kinase Signaling: AKT1, PIK3CA, PTEN.
Apoptosis: TNFRSF6B.
Cell Adhesion & Cytoskeleton: CSMD1, CTNND1.
Cell Cycle: CCND1, CDKN2A, MDM2.
Growth Factors: VEGFA.
RAS Signaling: KRAS.
Transcription Factors: MYC, NKX2-1, NKX2-8, RB1, SKIL, SOX2, TFDP1.
Tyrosine Kinase Receptors: EGFR, IGF1R, KIT, MET, PDGFRA, RB1.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Chromosomal aneuploidy and segmental copy number changes are common genomic aberrations in �cancer. Copy number alterations (CNAs) arise from deletions, insertions, or duplications resulting in �chromosomal aberrations and aneuploidy. Genomes
The characterization of molecular alterations specific to cancer facilitates the discovery of predictive and prognostic biomarkers important to targeted therapeutics. Alterations critical to cancer therapeutics include copy number alterations
Analyzing Cancer Samples with SNP Arrays
Single nucleotide polymorphism (SNP) arrays are powerful tools to delineate genomic aberrations in cancer genomes. However, the analysis of these SNP array data of cancer samples is complicated by three phenomena: (a) aneuploidy








